
Dedicated to extending healthy productive life for everyone on the planet. Covers advances in longevity, AI, robotics, cryonics, quantum, and other emerging technologies. Posts are strictly personal, not reflective of positions of Insilico Medicine.
| Platform | Pricing | Only free issues | Publishes | Weekly | |
|---|---|---|---|---|---|
| Issues | 35 | Founded | 2 years ago | Last Issue | 4 days ago |
| Active | |||||

I want to start with a number, because the number is the only thing that has ever made this worth doing.
One extra year of life for every person alive today is roughly 8.3 billion life years. Divide that by a human lifespan and you get abo...
Many of my friends and colleagues will remember my Longevity Pledge. I wrote it after more than two decades in this field, when I decided to formalize my commitment to one cause, and it contained a promise about my personal life. I wrote: “...
Many of us remember the 10 years of progress in AI from 2012 to 2022. Many great feats of capability demonstrations from image recognition in ImageNet, Atari Games, image generation using GANs, AlphaGo, molecular generation using GENTRL, th...
I am writing this article as I sit in Abu Dhabi airport after spending three weeks working with our team on projects that you will definitely hear about in the global media. Even at 2AM and the airport is vibrant with hundreds of people rus...
Disclosure: Alex Zhavoronkov is Founder, Chairman, Co-CEO and CBO of Insilico Medicine (HKEX: 3696). This essay is his personal point of view. References to company operating figures should be read together with the company’s formal public...
Subscribers, engagement, traffic and sponsorship for Forever.AI: AI, Robotics, Quantum, Longevity, Cryonics & BCI.
| Subscribers | Engagement | 77 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
The writers behind this newsletter.
Alex Zhavoronkov, PhD, is CEO of Insilico Medicine (HKEX:3696), a generative AI biotech, which nominated 30+ preclinical candidates and got into clinical trials. He's also an adjunct professor at the Buck Institute for Aging.
You can find recent issues that have been published by this newsletter on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to this newsletter, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch this newsletter as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact this newsletter using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like this newsletter. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.